Seven Bridges Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Seven Bridges Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,187	Closed	-$66K	–	158
2016 Q3	$66K	Buy	+1,187	New	+$66.1K	0.06%	142
2016 Q2	–	Sell	-1,668	Closed	-$77K	–	158
2016 Q1	$77K	Buy	1,668 +731	+78%	+$35.4K	0.06%	140
2015 Q4	$58K	Buy	+937	New	+$66K	0.06%	143

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Seven Bridges Advisors's KITE Position: Q4 2016 in Review

Seven Bridges Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 1,187 shares — an estimated $66K sold.

Seven Bridges Advisors first reported a position in KITE in Q4 2015 and held it in 3 quarters. The position peaked at $77K in Q1 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Seven Bridges Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Seven Bridges Advisors sold 1,187 Kite Pharma, Inc. shares in Q4 2016, an estimated $66K.
Seven Bridges Advisors first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 3 quarters.
Seven Bridges Advisors's Kite Pharma, Inc. position peaked at $77K in Q1 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Seven Bridges Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.